Activation of Human T-Cell Leukemia Virus Type 1tax Gene Expression in Chronically Infected T Cells

ABSTRACT Expression of human T-cell leukemia virus type 1 (HTLV-1) is regulated both by the HTLV-1 Tax transactivator and by cellular transcriptional factors binding to the viral long terminal repeat (LTR), suggesting that cellular signals may play a role in regulating viral expression. Treatment of cells chronically infected with HTLV-1, which express low levels of HTLV-1 RNAs and Tax protein, with phorbol esters (i.e., phorbol12-myristate 13- acetate [PMA]), phytohemagglutinin (PHA), sodium butyrate, or combinations of cytokines resulted in induction of HTLV- 1 gene expression. PMA or PHA treatment following cotransfection of HTLV-1 Tax expression plasmids resulted in synergistic activation of HTLV-1 LTR-directed gene expression, apparently involving tyrosine ki- nase- mediated pathways. These results suggest that cellular activation stimuli may cooperate with HTLV-1 Tax to enhance expression of integrated HTLV-1 genomes and thus may play a role in the pathogenesis of HTLV-1 disease.

[1]  K. Shimotohno,et al.  Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes , 1997, Oncogene.

[2]  D. Hafler,et al.  Variable immortalizing potential and frequent virus latency in blood-derived T-cell clones infected with human T-cell leukemia virus type I. , 1997, Blood.

[3]  J. Brady,et al.  The cellular stress response enhances human T-cell lymphotropic virus type 1 basal gene expression through the core promoter region of the long terminal repeat , 1997, Journal of virology.

[4]  S. Wain-Hobson,et al.  Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells. , 1996, Blood.

[5]  B. Howard,et al.  The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.

[6]  R. Roeder,et al.  Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA , 1996, Molecular and cellular biology.

[7]  K. Ohshima,et al.  DETECTION OF HUMAN T LYMPHOTROPHIC VIRUS TYPE I (HTLV‐I) DNA AND mRNA IN INDIVIDUAL CELLS BY POLYMERASE CHAIN REACTION (PCR) IN SITU HYBRIDIZATION (ISH) AND REVERSE TRANSCRIPTION (RT)‐PCR ISH , 1996, Hematological oncology.

[8]  H. Shih,et al.  Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP , 1996, Nature.

[9]  G. Franchini.  Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. , 1995, Blood.

[10]  R. Lal,et al.  Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat , 1995, Journal of virology.

[11]  M. Ando,et al.  In vivo proviral burden and viral RNA expression in T cell subsets of patients with human T lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis. , 1995, The American journal of tropical medicine and hygiene.

[12]  G. Perini,et al.  Recognition of bZIP proteins by the human T-cell leukaemia virus transactivator Tax , 1995, Nature.

[13]  A. Schepartz,et al.  Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax , 1995, Nature.

[14]  S. Wain-Hobson,et al.  Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy , 1995, Journal of virology.

[15]  M. Lairmore,et al.  Enhanced human T-cell lymphotropic virus type I expression following induction of the cellular stress response. , 1995, Virology.

[16]  T. Fujiyoshi,et al.  HTLV‐I messenger RNA is expressed in vivo in adult T‐cell leukemia/lymphoma patients: An in situ hybridization study , 1994, International journal of cancer.

[17]  J. Brady,et al.  Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Tax1 and Ets1 , 1993, Journal of virology.

[18]  R. Rousset,et al.  Functional and biochemical interaction of the HTLV‐I Tax1 transactivator with TBP. , 1993, The EMBO journal.

[19]  R. Gaynor,et al.  Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR. , 1993, Virology.

[20]  D. Markovitz,et al.  Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor , 1993, Journal of virology.

[21]  R. Lal,et al.  Characterization of human T-lymphotropic virus type I- and II-infected T-cell lines: antigenic, phenotypic, and genotypic analysis. , 1993, Virus research.

[22]  A. Fauci,et al.  The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.

[23]  M. Yoshida,et al.  The trans-activator tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Gaynor,et al.  Transcription factor AP‐2 activates gene expression of HTLV‐I. , 1992, The EMBO journal.

[25]  D. Hafler,et al.  T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Yuetsu Tanaka,et al.  Expression of Human T‐cell Lymphotropic Virus Type‐1 Gene Products in the Short‐term Cultured Skin Tissues of an Adult T‐cell Leukemia/Lymphoma Patient with Cutaneous Manifestations , 1992, The Journal of dermatology.

[27]  G. Pavlakis,et al.  Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I , 1992, Journal of virology.

[28]  J. Brady,et al.  Myb protein binds to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression. , 1992, Virology.

[29]  L. Zhao,et al.  Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Lairmore,et al.  HTLV‐I‐associated myelopathy endemic in Texas‐born residents and isolation of virus from CSF cells , 1991, Neurology.

[31]  W. Greene,et al.  Molecular biology of the type I human T-cell leukemia virus (HTLV-I) and adult T-cell leukemia. , 1991, The Journal of clinical investigation.

[32]  K. Jeang,et al.  Induction of the HTLV-I LTR by Jun occurs through the Tax-responsive 21-bp elements. , 1991, Virology.

[33]  Y. Itoyama,et al.  A Quantitative Polymerase Chain Reaction Study , 2004 .

[34]  J. Brady,et al.  The product of the c‐ets‐1 proto‐oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV‐1. , 1990, The EMBO journal.

[35]  H. Ioachim,et al.  Immunopathogenesis of human immunodeficiency virus infection. , 1990, Cancer research.

[36]  J. Brady,et al.  A 36-kilodalton cellular transcription factor mediates an indirect interaction of human T-cell leukemia/lymphoma virus type I TAX1 with a responsive element in the viral long terminal repeat , 1990, Molecular and cellular biology.

[37]  F. Sigaux,et al.  High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. , 1990, Blood.

[38]  K. Jeang,et al.  Activation of the human T-cell leukemia virus type I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate and by tax (p40x) occurs through similar but functionally distinct target sequences , 1989, Journal of virology.

[39]  J. Sodroski,et al.  Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  I. Boros,et al.  Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence , 1988, Journal of virology.

[41]  M. Karin,et al.  Transcription factor AP-2 mediates induction by two different signal-transduction pathways: Protein kinase C and cAMP , 1987, Cell.

[42]  R. K. Reynolds,et al.  The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. , 1987, Science.

[43]  K. Jeang,et al.  Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat , 1987, Journal of virology.

[44]  M. Dodon,et al.  Direct activation of resting T lymphocytes by human T-lymphotropic virus type I , 1987, Nature.

[45]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[46]  M. Takano,et al.  Requirement of multiple copies of a 21-nucleotide sequence in the U3 regions of human T-cell leukemia virus type I and type II long terminal repeats for trans-acting activation of transcription. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[47]  G. Pavlakis,et al.  Cis-acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Mitsuhiro Osame,et al.  HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.

[49]  M. Martin,et al.  Characterization of human endogenous retroviral envelope RNA transcripts , 1985, Journal of virology.

[50]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[51]  A. Weiss,et al.  Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line , 1984, The Journal of experimental medicine.

[52]  J. Sodroski,et al.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. , 1984, Science.

[53]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[54]  D. Dorsett,et al.  Quantitation of a simian virus 40 nonhomologous recombination pathway , 1983, Journal of virology.

[55]  B. Howard,et al.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.

[56]  M. Yoshida,et al.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[57]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[58]  E. Jaffe,et al.  Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. , 1980, Blood.

[59]  P. Chambon,et al.  Effect of histone acetylation on structure and in vitro transcription of chromatin. , 1978, Nucleic acids research.

[60]  R. Chalkley,et al.  The effect of sodium butyrate on histone modification , 1978, Cell.

[61]  V. Ingram,et al.  n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells , 1977, Nature.

[62]  T. Uchiyama.  Human T cell leukemia virus type I (HTLV-I) and human diseases. , 1997, Annual review of immunology.

[63]  S. Wain-Hobson,et al.  Clonal expansion of infected cells: a way of life for HTLV-I. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[64]  M. Yoshida,et al.  HTLV-1 oncoprotein tax and cellular transcription factors. , 1995, Current topics in microbiology and immunology.

[65]  G. Baier,et al.  Transcellular activation of the HTLV promoter by human hematopoietic cells. , 1994, Oncogene.

[66]  D. Bednarik,et al.  Mechanisms of HIV-1 latency. , 1992, AIDS.